Ketoconazole Shampoo: Effect of Long-Term Use in Androgenic Alopecia

TLDR

Androgenic alopecia’s pathogenesis is incompletely understood, with evidence that a microbial‑driven inflammatory reaction involving Malassezia spp. may contribute to follicular dysfunction. The study aimed to assess whether ketoconazole shampoo could improve androgenic alopecia by targeting scalp microflora and inflammation. The authors compared 2 % ketoconazole shampoo alone and with 2 % minoxidil against an unmedicated shampoo in a controlled trial.

Abstract

<b>Background:</b> The pathogenesis of androgenic alopecia is not fully understood. A microbial-driven inflammatory reaction abutting on the hair follicles might participate in the hair status anomaly. <b>Objective:</b> The aim of our study was to determine if ketoconazole (KCZ) which is active against the scalp microflora and shows some intrinsic anti-inflammatory activity might improve alopecia. <b>Method:</b> The effect of 2% KCZ shampoo was compared to that of an unmedicated shampoo used in combination with or without 2% minoxidil therapy. <b>Results:</b> Hair density and size and proportion of anagen follicles were improved almost similarly by both KCZ and minoxidil regimens. The sebum casual level appeared to be decreased by KCZ. <b>Conclusion:</b> Comparative data suggest that there may be a significant action of KCZ upon the course of androgenic alopecia and that <i>Malassezia </i>spp. may play a role in the inflammatory reaction. The clinical significance of the results awaits further controlled study in a larger group of subjects.